Earlier this month, Amgen announced that the FDA approved UPLIZNA (inebilizumab-cdon) for adults with generalized myasthenia gravis who are anti-AChR and anti-MuSK antibody positive, making it the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback